72135-75-2

Upstream product

• 906669-90-7 C₁₀H₁₁O₇S^(1-)*K⁽¹⁺⁾ 
• 91-52-1 2,4 dimethoxybenzoic acid 

Downstream Products

• 906669-92-9 2,4-dihydroxy-5-(N-methyl-N-propyl-sulfamoyl)-benzoic acid 
• 906669-91-8 2,4-dihydroxy-5-(N-methyl-N-propyl-sulfamoyl)-benzoic acid methyl ester 
• 72135-85-4 2,4-dimethoxy-5-methylsulphonyl benzoic acid 
• 72135-76-3 2,4-dimethoxy-5-mercaptobenzoic acid 
• 85855-48-7 5-aminosulfonyl-2,4-dimethoxybenzoic acid 

Relevant academic research and scientific papers

TRIAZOLE DERIVATIVES II

Novel triazole derivatives of the formula (I) in which R1—R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

TRIAZOLE DERIVATIVES

The invention relates to novel triazole derivatives of formula (I) wherein R1 - R6 and Y have the designations cited in patent claim 1. Said derivatives are HSP90 inhibitors, and can be used to produce a medicament for treating diseases wherefore the inhibition, regulation and/or modulation of HSP90 plays an important role.

N-(3-pyrrolidinyl) benzamide derivative

N-(3-Pyrrodinyl)benzamide derivatives represented by the following general formula (I) which have potent and selective antagonism against dopamine D3 and/or D4 receptor and are useful as a psychotropic, a schizophrenia-treating agent and the like, or a pharmaceutically acceptable salt thereof or a pharmaceutical preparation thereof. STR1

New substituted heterocyclic benzamides, methods of preparing them and their application as behavior modifiers

There are provided new substituted heterocyclic benzamides and derivativeshereof which provide modifications on the central nervous system.